Concepedia
Statistics
Publications
14
Citations
467
H-Index
13
Active since
2014
Affiliations
Rigshospitalet(Current)
Copenhagen University Hospital
University of Copenhagen
Herlev Hospital
Zealand University Hospital
Mads Emil Bjørn is an author at Rigshospitalet specializing in medicine, hematology, and myeloproliferative neoplasms.
Publications per year
2014–2024
Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
Anders Lindholm Sørensen, Stine Ulrik Mikkelsen, Trine Alma Knudsen et al. · Haematologica · 2019 · 105 citations · Full text
Medicine, Hematology, Pharmacology +15
Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase
Dres Damgaard, Mads Emil Bjørn, Maria Abildgaard Steffensen et al. · Arthritis Research & Therapy · 2016 · 58 citations · Full text
Life Sciences, Biochemistry, Immunology +16
Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn et al. · Cancer Medicine · 2018 · 45 citations · Full text
Medicine, Hematology, Pharmacology +16
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
Hans Carl Hasselbalch, Mads Emil Bjørn · PubMed · 2015 · 43 citations
Medicine, Hematology, Pharmacotherapy +13
Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase
Dres Damgaard, Mads Emil Bjørn, Peter Østrup Jensen et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2017 · 41 citations · Full text
Life Sciences, Biochemistry, Immunology +17
1–5 of 14